Effects of n-3 PUFA enriched and n-3 PUFA deficient diets in naive and Aβ-treated female ratsBove, M., Mhillaj, E., Tucci, P., Giardino, I., Schiavone, S., Morgese, M. G. & Trabace, L., Sep-2018, In : Biochemical Pharmacology. 155, p. 326-335 10 p.
Research output: Contribution to journal › Article › Academic › peer-review
Depression is one of the most common psychiatric diseases and the prevalence of depressive symptoms in women is almost twice compared to men, although the reasons of this gender difference are not fully understood yet. Recently, soluble A beta(1-42) peptide has been receiving great importance in the development of depression, also since depression is highly comorbid with Alzheimer's disease and other neurodegenerative illnesses. Accordingly, we have previously shown that central A beta injection is able to elicit depressive-like phenotype in male rats. In the present study, we reproduced for the first time the A beta-induced depressive-like model in female rats, evaluating behavioural and neurochemical outcomes. Moreover, we studied the effect of lifelong exposure to either n-3 PUFA enriched or n-3 PUFA deficient diet, in female rats, both intact and after central A beta administration. Our results confirmed the A beta-induced depressive-like profile also in female rats. Moreover, chronic exposure to n-3 PUFA deficient diet led to highly negative alterations in behavioural and neurochemical parameters, while lifelong exposure to n-3 PUFA enriched diet was able to restore the A beta-induced depressive-like profile in female rats. In conclusion, the A beta-induced depressive-like profile was reversed by n-3 PUFA supplementation, indicating a possible therapeutic role of n-3 PUFA in the treatment of the burden of depressive disorders.
|Number of pages||10|
|Publication status||Published - Sep-2018|
- PUFA, Soluble amyloid beta, Depressive-like profile, Female rats, DEPRESSIVE-LIKE BEHAVIOR, FATTY-ACID, DOCOSAHEXAENOIC ACID, GENDER-DIFFERENCES, SEX-DIFFERENCES, ALZHEIMERS-DISEASE, PREFRONTAL CORTEX, DOPAMINE, BRAIN, SEROTONIN